Ken Griffin’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,371
| Closed | -$11.7K | – | 6127 |
|
|
2025
Q1 | $11.7K | Buy |
+4,371
| New | +$11.7K | ﹤0.01% | 5676 |
|
|
2024
Q2 | – | Sell |
-673
| Closed | -$24.1K | – | 6147 |
|
|
2024
Q1 | $24.1K | Buy |
+673
| New | +$24.1K | ﹤0.01% | 5511 |
|
|
2022
Q4 | – | Sell |
-169
| Closed | -$13K | – | 6198 |
|
|
2022
Q3 | $13K | Sell |
169
-520
| -75% | -$40K | ﹤0.01% | 5604 |
|
|
2022
Q2 | $107K | Buy |
689
+122
| +22% | +$18.9K | ﹤0.01% | 5266 |
|
|
2022
Q1 | $349K | Buy |
567
+175
| +45% | +$108K | ﹤0.01% | 4801 |
|
|
2021
Q4 | $490K | Buy |
392
+341
| +669% | +$426K | ﹤0.01% | 4621 |
|
|
2021
Q3 | $142K | Buy |
+51
| New | +$142K | ﹤0.01% | 5635 |
|
|
2021
Q2 | – | Sell |
-76
| Closed | -$85K | – | 6564 |
|
|
2021
Q1 | $85K | Buy |
76
+52
| +217% | +$58.2K | ﹤0.01% | 5924 |
|
|
2020
Q4 | $32K | Buy |
+24
| New | +$32K | ﹤0.01% | 4926 |
|
|
2020
Q1 | – | Sell |
-29
| Closed | -$38K | – | 4955 |
|
|
2019
Q4 | $38K | Buy |
+29
| New | +$38K | ﹤0.01% | 4425 |
|
|
2019
Q3 | – | Sell |
-26
| Closed | -$59K | – | 4787 |
|
|
2019
Q2 | $59K | Buy |
+26
| New | +$59K | ﹤0.01% | 4327 |
|
|
2018
Q4 | – | Sell |
-41
| Closed | -$110K | – | 4611 |
|
|
2018
Q3 | $110K | Buy |
+41
| New | +$110K | ﹤0.01% | 3883 |
|
|
2016
Q1 | – | Hold |
0
| – | -$2K | – | 3508 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | -$22K | – | 3847 |
|
|
2015
Q3 | $22K | Buy |
2
+1
| +100% | +$11K | ﹤0.01% | 3715 |
|
|
2015
Q2 | $5K | Buy |
+1
| New | +$5K | ﹤0.01% | 3741 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$18K | – | 3819 |
|
|
2014
Q4 | $18K | Hold |
1
| – | – | ﹤0.01% | 3664 |
|
|
2014
Q3 | $10K | Buy |
+1
| New | +$10K | ﹤0.01% | 3439 |
|
|
2013
Q3 | – | Sell |
-1
| Closed | -$12K | – | 2980 |
|
|
2013
Q2 | $12K | Buy |
+1
| New | +$12K | ﹤0.01% | 2680 |
|